CGCCanopy Growth Corporation exhibits mixed investment signals. While it operates within the growing cannabis market, significant fundamental challenges, including consistent losses and negative cash flows, weigh heavily. Technical indicators suggest a strong downtrend, making it a speculative play for risk-tolerant investors.
Canopy Growth operates in the expanding global cannabis market, which presents long-term thematic growth potential. However, regulatory hurdles and evolving consumer preferences introduce considerable uncertainty.
Canopy Growth's financials reveal significant challenges. The company consistently reports substantial net losses and negative free cash flow, indicating operational inefficiencies and a need for substantial capital. While revenue has shown some fluctuations, profitability remains elusive.
Canopy Growth's stock is in a strong downtrend across multiple timeframes. It is trading well below key moving averages, and momentum indicators suggest ongoing weakness.
| Factor | Score |
|---|---|
| Cannabis Market Growth | 80 |
| Regulatory Landscape | 50 |
| Product Innovation & Diversification | 75 |
| Brand Strength & Market Position | 70 |
| ESG & Social Impact | 65 |
| Factor | Score |
|---|---|
| Valuation | 40 |
| Profitability | 10 |
| Growth | 20 |
| Balance Sheet Health | 35 |
| Cash Flow | 15 |
| Factor | Score |
|---|---|
| Trend Analysis | 20 |
| Momentum | 40 |
| Volume Confirmation | 50 |
| Support & Resistance | 30 |
| Volatility | 30 |
Market Capitalization
The current market capitalization is $244,604,080, indicating a relatively small-cap company with potential for growth.
Short-term Performance
The stock has shown positive performance over the last 5 days (+2.70%), suggesting recent positive investor sentiment.
Significant Long-Term Decline
The stock has experienced a substantial decline over the past year (-84.51%) and year-to-date (-60.42%), indicating significant investor concerns and potential fundamental issues.
Consistent EPS Misses
The company has consistently reported EPS below analyst estimates across all reported quarters, with significant negative surprises, indicating an inability to meet profit expectations.
August 2025
8
Next Earnings Date
H: $-0.12
A: $-0.12
L: $-0.12
H: 67.80M
A: 64.95M
L: 61.00M
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief, Ace Valley, and Vert brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
3.81 USD
The 39 analysts offering 1 year price forecasts for CGC have a max estimate of 3.81 and a min estimate of 3.81.